Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01548885 · ClinicalTrials.gov registry record · NA

Comparison Evaluation of Blood Glucose Meter Systems

A NA study of Diabetes, sponsored by Ascensia Diabetes Care.

Completed
Registry status
NA
Development phase
146
Enrollment target
1
Study location

NCT01548885 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 146 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01548885, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to evaluate the performance of one investigational Bayer Blood Glucose meter (with investigational Bayer test strips) and four Blood Glucose Monitoring Systems from other companies. All meter BG results were compared with plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer). Performance of the five systems was evaluated across the glucose range of the BGMSs using capillary blood. All testing and lancing were performed by study staff and some blood samples were glycolyzed to lower the glucose levels.

Conditions Studied

Interventions

  • DEVICE CONTOUR® NEXT EZ BGMS
  • DEVICE FreeStyle Freedom Lite® BGMS
  • DEVICE ACCU-CHEK® Aviva BGMS
  • DEVICE TRUEtrack® BGMS
  • DEVICE OneTouch® Ultra®2 BGMS

Study Locations (1)

Indiana

  • Bayer HealthCare LLC, Diabetes Care - Mishawaka

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2012-03
Est. Completion 2012-03
Phase NA

Sponsor

Ascensia Diabetes Care

42 total trials

What the Registry Record Tells You About NCT01548885

The ClinicalTrials.gov registry entry for NCT01548885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 5 interventions - of which CONTOUR® NEXT EZ BGMS is the first listed.

NCT01548885 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT01548885 about?

NCT01548885 is a clinical study titled "Comparison Evaluation of Blood Glucose Meter Systems". The purpose of this study was to evaluate the performance of one investigational Bayer Blood Glucose meter (with investigational Bayer test strips) and four Blood Glucose Monitoring Systems from other companies. All meter BG results were compared with plasma results obtained with a reference laborat...

What is the current status of trial NCT01548885?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2012-03. Estimated completion is 2012-03.

What conditions does trial NCT01548885 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01548885?

The interventions under investigation include: CONTOUR® NEXT EZ BGMS (DEVICE), FreeStyle Freedom Lite® BGMS (DEVICE), ACCU-CHEK® Aviva BGMS (DEVICE), TRUEtrack® BGMS (DEVICE), OneTouch® Ultra®2 BGMS (DEVICE).

Who is sponsoring clinical trial NCT01548885?

This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01548885 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.